EPS Bio Technology Corp. (TPEX:4183)

EPS Bio Technology Statistics

Total Valuation

TPEX:4183 has a market cap or net worth of TWD 384.37 million. The enterprise value is 376.58 million.

Market Cap	384.37M
Enterprise Value	376.58M

Important Dates

The next estimated earnings date is Wednesday, March 11, 2026.

Earnings Date	Mar 11, 2026
Ex-Dividend Date	Aug 28, 2025

Share Statistics

TPEX:4183 has 23.80 million shares outstanding. The number of shares has decreased by -0.05% in one year.

Current Share Class	23.80M
Shares Outstanding	23.80M
Shares Change (YoY)	-0.05%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	52.90%
Owned by Institutions (%)	n/a
Float	8.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
PB Ratio	1.36
P/TBV Ratio	1.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-26.45
EV / Sales	0.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-20.65

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.36.

Current Ratio	2.43
Quick Ratio	1.72
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	-5.60
Interest Coverage	-9.18

Financial Efficiency

Return on equity (ROE) is -4.77% and return on invested capital (ROIC) is -6.61%.

Return on Equity (ROE)	-4.77%
Return on Assets (ROA)	-2.03%
Return on Invested Capital (ROIC)	-6.61%
Return on Capital Employed (ROCE)	-4.64%
Revenue Per Employee	4.56M
Profits Per Employee	-130,606
Employee Count	109
Asset Turnover	0.91
Inventory Turnover	4.18

Taxes

Income Tax	-5.24M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.28% in the last 52 weeks. The beta is 0.20, so TPEX:4183's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	-31.28%
50-Day Moving Average	17.04
200-Day Moving Average	19.70
Relative Strength Index (RSI)	35.66
Average Volume (20 Days)	14,873

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4183 had revenue of TWD 497.19 million and -14.24 million in losses. Loss per share was -0.60.

Revenue	497.19M
Gross Profit	75.56M
Operating Income	-17.71M
Pretax Income	-19.48M
Net Income	-14.24M
EBITDA	-7.18M
EBIT	-17.71M
Loss Per Share	-0.60

Balance Sheet

The company has 109.95 million in cash and 102.17 million in debt, with a net cash position of 7.79 million or 0.33 per share.

Cash & Cash Equivalents	109.95M
Total Debt	102.17M
Net Cash	7.79M
Net Cash Per Share	0.33
Equity (Book Value)	283.28M
Book Value Per Share	11.90
Working Capital	203.95M

Cash Flow

In the last 12 months, operating cash flow was -4.05 million and capital expenditures -14.19 million, giving a free cash flow of -18.23 million.

Operating Cash Flow	-4.05M
Capital Expenditures	-14.19M
Free Cash Flow	-18.23M
FCF Per Share	-0.77

Margins

Gross margin is 15.20%, with operating and profit margins of -3.56% and -2.86%.

Gross Margin	15.20%
Operating Margin	-3.56%
Pretax Margin	-3.92%
Profit Margin	-2.86%
EBITDA Margin	-1.44%
EBIT Margin	-3.56%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.67, which amounts to a dividend yield of 4.19%.

Dividend Per Share	0.67
Dividend Yield	4.19%
Dividend Growth (YoY)	-16.25%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.05%
Shareholder Yield	4.18%
Earnings Yield	-3.70%
FCF Yield	-4.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 8, 2014. It was a forward split with a ratio of 1.04.

Last Split Date	Oct 8, 2014
Split Type	Forward
Split Ratio	1.04

Scores

TPEX:4183 has an Altman Z-Score of 2.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.62
Piotroski F-Score	3